Therefore, an approach that inhibits AGEs-RAGE induced activation of RhoA/ROCK/moesin signaling pathway is expected to attenuate the cerebral microangiopathy and thus prevent the cognition impairment in T2DM. Here, RHOA is linked to type 2 diabetes mellitus.